Willem P. Brouwer

Rotterdam, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 95 publications

Liver stiffness dynamics in European populations - Authors' reply.

Liver stiffness dynamics in European populations - Authors' reply.

Journal: The lancet. Gastroenterology & hepatology
Published: August 10, 2026

Reply to Jiang et al.

Reply to Jiang et al.

Journal: The American journal of gastroenterology
Published: July 22, 2026

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: May 19, 2026

Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver Organoids.

Urinary Volatile Organic Compound Metabolites Are Associated With MASLD/MASH in Humans and Induce Steatosis in Liver Organoids.

Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: April 23, 2026

Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.

Validated Early Detection Metrics Reduce the Population Requiring Liver Fibrosis Screening.

Journal: Gastroenterology
Published: March 09, 2026

Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.

Impact of Fibrotic Metabolic Dysfunction-Associated Steatohepatitis as a New Indication on Semaglutide Eligibility in the US Adult Population.

Journal: Gastro hep advances
Published: January 26, 2026

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.

Steatotic liver disease trajectory: A holistic EASL guidance on the multidisciplinary approach to screening and patient management.

Journal: JHEP reports : innovation in hepatology
Published: January 20, 2026

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.

Liver stiffness dynamics in European populations (LiverScreen): a longitudinal, multicentre, prospective, population-based cohort study.

Journal: The lancet. Gastroenterology & hepatology
Published: January 05, 2026

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Resmetirom: An Update on Therapy for Metabolic Dysfunction-Associated Steatohepatitis (MASH).

Journal: Drug design, development and therapy
Published: December 08, 2025

Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.

Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver disease.

Journal: The Lancet regional health. Europe
Published: December 04, 2025

Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study.

Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study.

Journal: Hepatology communications
Published: December 03, 2025

Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study.

Two-step care pathways for advanced MASLD in primary and hospital care: A multicenter study.

Journal: Hepatology communications
Published: December 03, 2025
Showing 1-12 of 95

Last Updated: 09/26/2026